The Optima Group will be exhibiting two machines at Expo Pack. The international trade show for the packaging industry will be held from June 11 to 13 in Guadalajara, Mexico. Visitors can get an impression of the company’s expertise from the machines on display: the OPTIMA FM1 and the SD €co. Optima experts will also be on hand with information about the Group's entire portfolio.

The new Optima logistics centre went live in March 2019. The employees mastered the move and the go-live in record time. We accompanied the move for you with our camera.

Optima Pharma focused on the virtual presentation of new technologies at Interphex 2019. The trade show in New York is one of the most important events for decision-makers in the pharmaceutical and biotech industries on the American continent. After winning the ICE Award at ICE Europe, Optima has won another trade show prize.

Three characters, three perspectives. At IDEA 2019 in Miami, Optima Nonwovens looked through the lenses of an operations manager, a plant manager, and a machine operator: Tom, Lisa, and Carl all want to create efficient and robust processes for packaging of paper hygiene products – and yet they each have their own specifications. The animated characters quickly won over hearts and attracted a crowd of visitors to Optima Nonwovens’ trade show booth.

An award in the bag and plenty of new contacts forged – now that ICE Europe in Munich has drawn to a close, Optima Life Science is taking a look back on a successful trade show. The films with pharmaceutical ingredients and the corresponding production and assembly technology from the COMEDCO alliance impressed industry experts. The COMEDCO complete solution for transdermal patches (TDPs) and orally disintegrating films (ODFs) received the ICE Award for “Special Film Innovations”, chosen by the trade show visitors through an online vote. The award ceremony was held on March 12 at ICE Europe in Munich.

Optima Pharma and Charité – Universitätsmedizin Berlin are developing a concept for the automated production and filling of cell and gene therapeutics. These new types of medications are considered a promising new therapy opportunity for incurable cancer and metabolic diseases. They also pave the way for personalized medication. These medications depend on the patient’s cells. They are still produced manually, for each individual patient, which is very expensive. The innovative project is financed by the Berlin Institute of Health (BIH).